QUINIDINE - POTENT INHIBITION OF SPARTEINE AND DEBRISOQUINE OXIDATION INVIVO

被引：67
作者：
INABA, T
TYNDALE, RE
MAHON, WA
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 22卷 / 02期
关键词：
D O I：
10.1111/j.1365-2125.1986.tb05251.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 7 条
[1]  
EICHELBAUM M, 1984, FED PROC, V43, P2298
[2]  
INABA T, 1985, DRUG METAB DISPOS, V13, P443
[3]   COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE [J].
INABA, T ;
VINKS, A ;
OTTON, SV ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :394-399
[4]  
KALOW W, 1984, FED PROC, V43, P2326
[5]  
LEEMANN T, 1986, EUR J CLIN PHARM
[6]   OXIDATION PHENOTYPE AND THE METABOLISM AND ACTION OF BETA-BLOCKERS [J].
LENNARD, MS .
KLINISCHE WOCHENSCHRIFT, 1985, 63 (07) :285-292
[7]   COMPETITIVE-INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY BETA-ADRENOCEPTOR ANTAGONISTS AND OTHER CARDIOVASCULAR DRUGS [J].
OTTON, SV ;
INABA, T ;
KALOW, W .
LIFE SCIENCES, 1984, 34 (01) :73-80
1